ASSURE-CSU- ASSESSING THE IMPACT OF CHRONIC SPONTANEOUS / IDIOPATHIC URTICARIA ON WORK PRODUCTIVITY AND ACTIVITY

Author(s)

McBride D1, Balp M2, Abuzakouk M3, Berard F4, Canonica GW5, Gimenez-Arnau A6, Grattan C7, Knulst AC8, Hollis K9, Khalil S2, Lacour J10, Lynde C11, Marsland A12, Nakonechna A13, Ortiz de Frutoz FJ14, Oude Elberink J15, Proctor C9, Sussman G16, Weller K17, Maurer M17
1RTI Health Solutions, Manchester, UK, 2Novartis Pharma AG, Basel, Switzerland, 3Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 4Claude Bernard University Lyon, Lyon, France, 5University of Genoa, Genoa, Italy, 6Hospital del Mar. Parc de Salut Mar, Barcelona, Spain, 7Norfolk and Norwich University Hospital, Norwich, UK, 8University Medical Center Utrecht, Utrecht, The Netherlands, 9RTI Health Solutions, Research Triangle Park, NC, USA, 10Université Nice Sophia Antipolis, Nice Cedex 2, France, 11Lynderm Research Inc., Toronto, ON, Canada, 12Salford Royal Hospital, Salford, UK, 13Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK, 14Hospital 12 Octubre, Madrid, Spain, 15University of Groningen, Groningen, The Netherlands, 16University of Toronto, Toronto, ON, Canada, 17Charite - Universitätsmedizin Berlin, Berlin, Germany

Presentation Documents

OBJECTIVES: Chronic spontaneous/idiopathic urticaria (CSU), defined as the spontaneous appearance of itchy hives, angioedema, or both for ≥6 weeks, has a significant yet underestimated impact on patients’ work productivity. The ASSURE-CSU study aimed to identify and quantify the humanistic and economic burden of CSU. We present here data on work productivity and activity impairment. METHODS: Patients with CSU for ≥12 months, aged ≥18 years, symptomatic despite treatment were recruited in 7 countries (Canada, France, Germany, Italy, Netherlands, Spain, UK). Data were collected on absenteeism, presenteeism and activity impairment over the previous 7 days via the Work Productivity and Activity Impairment–Specific Health problem (WPAI-SHP) questionnaire. Descriptive statistics were provided and stratified by disease activity, measured by the Urticaria Activity Score (UAS) daily diary, which has a range from 0-42 for the weekly score (UAS7). RESULTS:

Conference/Value in Health Info

2016-05, ISPOR 2016, Washington DC, USA

Value in Health, Vol. 19, No. 3 (May 2016)

Code

PSS17

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Work & Home Productivity - Indirect Costs

Disease

Sensory System Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×